12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Owlet (NYSE:OWLT) shares rose 43.8% to $0.49 during Monday’s after-market session. At the close, Owlet’s trading volume…
Metacrine, Equillium And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Metacrine and Equillium Mutually Agree to Terminate Definitive Merger Agreement
Metacrine, Inc. (NASDAQ:MTCR) and Equillium, Inc. today announced the mutual termination of their previously announced definitive merger agreement. Metacrine is continuing to evaluate all strategic opportunities.
Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 293 companies set new 52-week lows.
Why iBio Shares Are Trading Lower By Around 48%; Here Are 23 Stocks Moving Premarket
Gainers
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 71.3% to $0.7190 in pre-market trading after the company reported withdrawal of registration statement.
Autoimmune Biotech Scores $26M Payment, Up To $139M To Advance Phase 3 Research
Equillium Inc (NASDAQ:EQ) announced an option and asset purchase agreement through which Ono Pharmaceutical Co Ltd gains the exclusive option to purchase Equillium’s…
Equillium Announces Initiation Of Phase 2 Study Of EQ101 A First-in-Class Multi-Cytokine Inhibitor Of IL-2, IL-9 And IL-15 Targeting Alopecia Areata
Equillium, Inc. (NASDAQ:EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it has
